Susan Hasty, Publisher
Table of Contents . . . May 3rd, 1999Non-Subscriber - Summaries Only
AIDS Vaccines - Mucosal Protection: Simpler Than Blood Protection?
AIDS Therapies - DCQAs Irreversibly Inhibit HIV-1 Integrase
AIDS Vaccines - Roadblock in Quest To Block HIV Binding
Toxicities - Eye Disease Develops Following HAART
Cancer Immunotherapy - Chimeric Immune Receptors Target Viruses and Cancer
Combination Therapy - Antiretrovirals Saquinavir/Ritonavir Safe and Effective
Epidemiology - ACTG Study Finds Prior TB to Predict MDR-TB in HIV+
HIV Assay - Serotyping Differentiates HIV Subtypes
Clinical Trials - Study on Women and HIV Enrolling Patients
Epidemiology - HIV Rates in Swaziland Remain High
HIV Vaccine - Company Acquires Worldwide Rights to Vaccine
HIV Vaccine (Animal Models) - Vaccine Provides Protection from HIV In Monkeys
Needle Safety - Technology Protects Patients
Therapy Compliance - Physicians Urge Patients to Keep Taking Anti-HIV Medication
Drug Development - "Inhibition of HIV-1 Integrase by Acyclic Nucleoside Phosphonates."
Drug Development (Antiviral) - "Construction of an Anti-HIV-1 Integrase Diabody for Use in Co-Crystallization Studies with HIV-1 Integrase."
HIV Vaccines - "DNA and Protein Immunogens for SIV/HIV Vaccines."
Immunology (AIDS) - "Virus Specific T Cell Immunity In Primate AIDS."
Immunology (HIV) - "Immunogenicity of Deglycosylated SIV ENV Proteins."
Immunology - "Natural Immunity and HIV Disease Progression."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.